Back to search

Multidrug resistance-1 (MDR-1) in rheumatic autoimmune disorders. Part II: Increased P-glycoprotein activity in lymphocytes from systemic lupus erythematosus patients might affect steroid requirements for disease control.

Data up to Jan 2025

Published2000
Citations51
References0
Clinical Trials (1)

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

No citing papers found in database

Multidrug resistance-1 (MDR-1) in rheumatic autoimmune disorders. Part II: Increased… (2000) – PubMed | Metascience Observatory Explorer